Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04084652
Other study ID # 190206/B/07UOE
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 15, 2019
Est. completion date December 11, 2019

Study information

Verified date May 2022
Source University of Exeter
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Dietary protein is vital for the preservation of health and optimal adaptation to training. However, traditional animal proteins come with a number of economic, environmental, and ethical issues. Accordingly, there is a need to develop an understanding of the utility of more sustainable non-animal derived dietary proteins to support our nutrition. Mycoprotein, produced by Quorn Foods™, has recently been shown to stimulate a greater anabolic response within skeletal muscle compared with milk protein, suggesting its utility within sports nutrition. However, it is unclear what accounted for the greater anabolic response of mycoprotein. One explanation could be the non-protein nutrients contained within mycoprotein (e.g. fibre, carbohydrate, fat or micronutrients). Therefore, the present study will compare the muscle anabolic response between mycoprotein (MYC) as a whole food and the protein isolated from mycoprotein (PIM).


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date December 11, 2019
Est. primary completion date December 11, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years to 40 Years
Eligibility Inclusion Criteria: - BMI between 18 and 30. - Resistance trained Exclusion Criteria: - Any metabolic impairments. - Cardio/pulmonary diseases. - Chronic use of over the counter pharmaceuticals - A personal or family history of epilepsy, seizures or schizophrenia. - Allergic to mycoprotein/Quorn/edible fungi/environmental mould products.

Study Design


Related Conditions & MeSH terms

  • Anabolic Response to Mycoprotein and Micronutrient Ingeston

Intervention

Dietary Supplement:
Mycoprotein ingestion
The ingestion of mycoprotein

Locations

Country Name City State
United Kingdom University of Exeter Exeter

Sponsors (2)

Lead Sponsor Collaborator
University of Exeter Quorn

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Muscle protein synthesis The rate of synthesis of new muscle protein (Fractional Synthetic Rate %/h) 7.5 hours
Secondary Plasma Amino Acid Kinetics The rate of appearance of amino acids ingested in the drink 7.5 hours
Secondary Blood Glucose The levels of glucose in the blood 7.5 hours
Secondary Serum Insulin The levels of insulin in blood serum 7.5 hours